BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Cantor Fitzgerald
Farmers Insurance

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,126,968

« Back to Dashboard

Which drugs does patent 6,126,968 protect, and when does it expire?

Patent 6,126,968 protects AZILECT and is included in one NDA. There has been one Paragraph IV challenge on Azilect.

This patent has fourteen patent family members in twelve countries.

Summary for Patent: 6,126,968

Title: Stable compositions containing N-propargyl-1-aminoindan
Abstract:A pharmaceutical composition comprising as active ingredient a racemic, S(-), and R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof, and at least 60% by weight of at least one pentahydric or hexahydric alcohol. Optionally the composition may contain citric acid and magnesium stearate.
Inventor(s): Peskin; Tirtsah Berger (Raanana, IL), Caciularu; Fanny (Tikva, IL)
Assignee: Teva Pharmaceutical Industries, Ltd. (Jerusalem, IL)
Application Number:09/043,475
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
TevaAZILECTrasagiline mesylateTABLET;ORAL021641-001May 16, 2006ABRXYesNo► Subscribe► SubscribeY► Subscribe
TevaAZILECTrasagiline mesylateTABLET;ORAL021641-002May 16, 2006ABRXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,126,968

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Israel115357Sep 20, 1995
PCT Information
PCT FiledSeptember 18, 1996PCT Application Number:PCT/IL96/00115
PCT Publication Date:April 10, 1997PCT Publication Number: WO97/12583

International Patent Family for Patent: 6,126,968

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany69637096► Subscribe
Denmark0858328► Subscribe
European Patent Office0858328► Subscribe
Australia728524► Subscribe
Canada2232310► Subscribe
Spain2287940► Subscribe
Australia6942796► Subscribe
Austria362755► Subscribe
Hungary9802999► Subscribe
Hungary225859► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: